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論文の内容の要旨 
 
 (目的)  
 Over the past decade, epigenetic modification has been considered to play fundamental roles in cell regulatory 
processes and human diseases. Hydroxymethylcytosine (hmC) is a modified form of cytosine, which is 
enzymatically converted from methylcytosine (mC) by tet methylcytosine dioxygenase (TET) proteins (TET 1-3). 
While mC is a well-known epigenetic mark, little is known about its distribution and function. Although changes 
in methylation with aging have been variably described, very little information is available on the relationship 
between hmC and aging. We found that genomic hmC content was inversely correlated with age in T cells in 
human and mouse. The mechanism of hmC alteration with age, however, remains to be elucidated. 
 He conducted this study to clarify mechanisms of the age-dependent decrease of the hmC content and 
responsible TET proteins. 
(対象と方法) 
U1.T cell preparation:U Human CD3-positive cells were obtained from peripheral blood of 53 healthy volunteers 
(20-83 years). Mouse CD3-positive cells were prepared from spleen of 10 6-10-week-old and 10 1.5-2 year-old 
C57BL/6 mice.  
 
U2.Analysis of hmC and mCU: Genomic region containing hmC was enriched by the hydroxymethylated DNA 
immunoprecipitation (hMeDIP) method, and analyzed by real time PCR. Genomic region containing mC was 
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enriched by the Methylminer Methylated DNA Enrichment Kit, and analyzed by real time PCR. 
U3.Northern blot analysisU: Northern blot analysis was used to detect the new exon and the various sizes of TET3 
mRNA in different cell types.  
U4.Analysis of the newly identified age-dependent hmC region:U The newly identified age-dependent hmC region 
(ADHR) of mouse was amplified by PCR and inserted in the pGL3 basic vector (ADHR-pGL3basic). 
ADHR-pGL3basic was methylated by a CpG methyltransferase. 293T cells were co-transfected with 
methylated-ADHR-pGL3basic and mouse TET3-pcDNA4. hmC and mC analysis were performed by hMeDIP kit 
and Methylminer Methylated DNA Enrichment Kit, respectively, followed by real-time PCR. 
(結果) 
U1.Genomic hmC levels and expression levels of TET family genesU. 
He found that the mRNA expression levels of TET1 and TET3 were significantly decreased with age in human T 
cells, while those of TET2 were not changed with age. Because the preliminary results indicated that the genomic 
hmC content was decreased with age, he directly compared the genomic hmC content with the mRNA expression 
levels of TET1, TET2, and TET3, and found that  the mRNA expression levels of TET3 were significantly 
correlated with the hmC content, while those of TET1 and TET2 were not.  
 He then examined mRNA expression levels of mouse T cells. As he expected, the mRNA expression 
levels of TET1 and TET3 in aged mouse T cells were significantly lower than those in young mouse T cells, while 
those of TET2 were not changed with age  
U2.Mechanism of age-dependent regulation of TET3 expression U. 
He checked the hmC level in regions which are located on CpG island and at the upstream or gene body of mouse 
TET1 and TET3. He found that a region spanning about 300 bp at the upstream of TET3 showed higher hmC 
levels in young mouse T cells than those in aged mouse T cells. This region was located about 13 kb from the first 
coding exon of mouse TET3. In TET1, hmC levels were not different between young and aged mouse T cells. 
 In human, he also found a region with 79% homology with that of mouse located approximately 60 kb 
upstream of the first coding exon of human TET3. The hmC levels in this region were decreased with age. In 
contrast, the mC levels in this region were not different between young and aged human T cells. 
U3.Discovery of a new exon at the upstream of mouse and human TET3 
The database of mRNA sequencing indicated that the human ADHR was overlapped with the 700 bp transcribed 
region, which he designated exon 0. By RT-PCR analysis using primers made from exon 0 to exon 1, the PCR 
product with the expected size, with the 13-kb deduced intron spliced out, was visualized, demonstrating that exon 
0 was indeed expressed as a part of mRNA. The expression levels of exon 0-containing mRNA was higher in 
human T cells prepared from two volunteers at 22 years old and 29 years old than those prepared from volunteers 
at 62 years old and 69 years old, and than several human cell lines (Jurkat, 293T, Hela).  
 He then examined the mRNA species by Northern blot for two mouse cell lines, NIH3T3 fibroblast cell 
line and EL4 lymphoblastic lymphoma cell line, using the probe corresponding to a part of the mouse version of 
exon 0 and exon 3. A single mRNA species corresponding to an expected size of 11.6 kb was detected with the 
exon 0 probe in both cell lines, showing a higher expression level in EL4 than in NIH3T3. When the exon 3 probe 
was used, the size of main mRNA species expressed in NIH3T3 appeared to be shorter than that expressed in EL4, 
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possibly corresponding to the mRNA species with (EL4) and without (NIH3T3) exon 0. 
U4.Experimental conversion of mC to hmC in mouse ADHR by TET3  
In 293T cells co-transfected with the methylated-ADHR-pGL3basic and mouseTET3-pcDNA4, he found that the 
hmC level in ADHR was increased compared to the controls, indicating that a part of mC in the ADHR was 
converted to hmC by exogenously expressed mouse TET3. In contrast, the change of mC level in ADHR was 
undetectable, indicating that only a small part of mC was converted to hmC.  
(考察) 
He demonstrated a dramatic age-dependent decrease in the genomic hmC content in both human and mouse T 
cells. This could be caused by the gradual decrease in the TET3 expression levels during aging. The decrease in 
the genomic hmC content might play a role in alteration of the T cell function in elderly people.  
 
審査の結果の要旨 
 
(批評)  
 本研究では、ハイドロキシメチールシトシン（hmC）が加齢に伴い減少する分子機構を明らかにする
ことを目的とした。彼は、ヒトおよびマウスの T細胞において、ゲノムの hmCが年齢依存的に減少する
ことを見いだした。さらに、mCから hmCに変換する TETファミリー蛋白(TET1-3)の TET3mRNA発現が hmC
量と関連していること、加齢とともに減少することなどを明らかにした。以上の結果から、加齢 T細胞
において、TET3発現がエピジェネテイックに hmC発現を制御している可能性を明らかにした。本研究成
果はすでに国際雑誌に掲載され、世界的に高い評価を得ている。 
平成 27 年 1 月 7 日、学位論文審査委員会において、審査委員全員出席のもと論文について説明を求
め、関連事項について質疑応答を行い、最終試験を行った。その結果、審査委員全員が合格と判定した。 
よって、著者は博士（医学）の学位を受けるのに十分な資格を有するものと認める。 
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